Switzerland buys access to potential Covid-19 treatment drug
The drug could also be administered to risk groups and those in front-line jobs, the Health Office said.
Keystone / Alessandro Crinari
The Swiss government has signed an agreement with a Zurich company for priority access to a drug being developed to treat those severely ill with Covid-19.
This content was published on
1 minute
Keystone-SDA/dos
Português
pt
A Suíça compra acesso ao potencial medicamento de tratamento para o Covid-19
The deal with the Molecular Partners firm gives Switzerland access to the first 200,000 doses of the medicine, as well as up to three million further doses when requested, the Federal Office for Public Health (FOPH) announcedExternal link on Tuesday.
The deal is worth several million francs, the Keystone-SDA news agency reported.
The immunotherapeutic agent, currently in development, is “comparable to mixtures of antibody therapies that are used to neutralise the virus”, the FOPH wrote. If approved, it would mainly be used to treat people already infected with Covid-19, although it could also be administered to risk groups as a prophylactic.
Clinical trials of the drug are planned for Autumn 2020.
The deal is another leg of the government’s anti-coronavirus strategy. It has also put aside CHF300 million ($329 million) for the procurement of a vaccine, and last week announced the pre-purchase of up to 4.5 million doses of a drug being developed by US firm Moderna.
Popular Stories
More
Banking & Fintech
UBS releases ‘hundreds’ of staff in fresh wave of job cuts
Should Switzerland take measures to support its struggling industries?
Industrial policies are back in fashion, not only in the United States but also in the EU. Should Switzerland, where various industries are struggling, draw inspiration from such policies?
As a Swiss Abroad, how do you feel about the emergence of more conservative family policies in some US states?
In recent years several US states have adopted more conservative policies on family issues, abortion and education. As a Swiss citizen living there, how do you view this development?
This content was published on
A committee of Switzerland’s House of Representatives has found the people’s initiative to limit fireworks too extreme, but has suggested a counter-proposal.
UN investigators report evidence of crimes in Syria and call for national dialogue
This content was published on
UN investigators in Geneva report ample evidence of crimes in Syria and urge the regime to follow through on its promise of a national dialogue.
Swiss Trade Union warns EU deal could threaten wages
This content was published on
The Swiss Trade Union Federation warns that the new bilateral agreement between Switzerland and the EU could threaten wage protection and public services.
Credit Suisse fines from Mozambique scandal to fund victims’ compensation
This content was published on
The fines imposed on Credit Suisse for the Mozambique scandal will be allocated to a fund for the victims, amounting to $105.5 million.
‘Confederation is a subsidy machine’: Swiss finance minister
This content was published on
The Swiss government is a machine for distributing subsidies to various actors in the country, says finance minister Karin Keller-Sutter.
Lack of funds ends third bid to salvage Säntis ship from Swiss lake
This content was published on
A third attempt to salvage the steamship Säntis, lying at the bottom of Lake Constance in Switzerland since 1933, has failed before it has even begun.
Nestlé Waters on trial in France over illegal waste dumps
This content was published on
Bottled water producer Nestlé Waters to stand trial, accused of illegally dumping waste and maintaining unauthorised dumps.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Government earmarks CHF300 million to secure Covid-19 vaccine
This content was published on
The Swiss government is setting aside funds to procure enough doses of a Covid-19 vaccine for the country’s 8.6 million population.
Switzerland pre-orders 4.5 million doses of Covid-19 vaccine
This content was published on
The Swiss government has signed a deal with US biotech firm Moderna to secure early access to 4.5 million doses of a Covid-19 vaccine currently in development.
This content was published on
It’s the question we all want an answer to: when will there be a vaccine against Covid-19? And how is fair access being negotiated?
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.